These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 15184080)

  • 1. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
    Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
    Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation.
    Sahara N; Murayama M; Lee B; Park JM; Lagalwar S; Binder LI; Takashima A
    Eur J Neurosci; 2008 Jun; 27(11):2897-906. PubMed ID: 18540881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta.
    Liu F; Iqbal K; Grundke-Iqbal I; Gong CX
    FEBS Lett; 2002 Oct; 530(1-3):209-14. PubMed ID: 12387894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
    Reynolds CH; Betts JC; Blackstock WP; Nebreda AR; Anderton BH
    J Neurochem; 2000 Apr; 74(4):1587-95. PubMed ID: 10737616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
    An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ
    J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compound C enhances tau phosphorylation at Serine
    Majd S; Koblar S; Power J
    Neurosci Lett; 2018 Mar; 670():53-61. PubMed ID: 29398519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14-3-3zeta facilitates GSK3beta-catalyzed tau phosphorylation in HEK-293 cells by a mechanism that requires phosphorylation of GSK3beta on Ser9.
    Li T; Paudel HK
    Neurosci Lett; 2007 Mar; 414(3):203-8. PubMed ID: 17317006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
    Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
    Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents.
    Mai L; Jope RS; Li X
    J Neurochem; 2002 Jul; 82(1):75-83. PubMed ID: 12091467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants.
    Flaherty DB; Soria JP; Tomasiewicz HG; Wood JG
    J Neurosci Res; 2000 Nov; 62(3):463-72. PubMed ID: 11054815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-related receptor gamma regulates dopaminergic neuronal phenotype by activating GSK3β/NFAT signaling in SH-SY5Y cells.
    Lim J; Choi HS; Choi HJ
    J Neurochem; 2015 May; 133(4):544-57. PubMed ID: 25727910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-dependent kinase 5 immunoreactivity for granulovacuolar degeneration.
    Nakamori M; Takahashi T; Yamazaki Y; Kurashige T; Yamawaki T; Matsumoto M
    Neuroreport; 2012 Oct; 23(15):867-72. PubMed ID: 22968343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways.
    Hu JP; Xie JW; Wang CY; Wang T; Wang X; Wang SL; Teng WP; Wang ZY
    Brain Res Bull; 2011 May; 85(3-4):194-200. PubMed ID: 21435383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
    Watamura N; Toba J; Yoshii A; Nikkuni M; Ohshima T
    J Neurosci Res; 2016 Jan; 94(1):15-26. PubMed ID: 26400044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WW domain-containing oxidoreductase promotes neuronal differentiation via negative regulation of glycogen synthase kinase 3β.
    Wang HY; Juo LI; Lin YT; Hsiao M; Lin JT; Tsai CH; Tzeng YH; Chuang YC; Chang NS; Yang CN; Lu PJ
    Cell Death Differ; 2012 Jun; 19(6):1049-59. PubMed ID: 22193544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for Alzheimer's disease.
    Papasozomenos SCh; Shanavas A
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1140-5. PubMed ID: 11805297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.
    Sengupta A; Kabat J; Novak M; Wu Q; Grundke-Iqbal I; Iqbal K
    Arch Biochem Biophys; 1998 Sep; 357(2):299-309. PubMed ID: 9735171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A.
    Nicolia V; Fuso A; Cavallaro RA; Di Luzio A; Scarpa S
    J Alzheimers Dis; 2010; 19(3):895-907. PubMed ID: 20157245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
    Imahori K; Uchida T
    J Biochem; 1997 Feb; 121(2):179-88. PubMed ID: 9089387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease.
    Sze CI; Su M; Pugazhenthi S; Jambal P; Hsu LJ; Heath J; Schultz L; Chang NS
    J Biol Chem; 2004 Jul; 279(29):30498-506. PubMed ID: 15126504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.